<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mobihealthnews&#187; drug safety</title>
	<atom:link href="http://mobihealthnews.com/tag/drug-safety/feed/" rel="self" type="application/rss+xml" />
	<link>http://mobihealthnews.com</link>
	<description>mobihealthnews - the daily mHealth industry monitor.  Subscribe for our free weekly e-newsletter!</description>
	<lastBuildDate>Thu, 24 May 2012 12:07:24 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Roche inks deal with sleep monitoring start-up</title>
		<link>http://mobihealthnews.com/5215/roche-inks-deal-with-sleep-monitoring-start-up/</link>
		<comments>http://mobihealthnews.com/5215/roche-inks-deal-with-sleep-monitoring-start-up/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 10:00:45 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[adverse effects]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[NeuroVigil]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[TEDMED]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=5215</guid>
		<description><![CDATA[As we hinted last week, Wireless sensor and neuropathology start-up NeuroVigil has inked a deal with Swiss pharamceutical company Roche. NeuroVigil will provide Roche with its iBrain wireless sensors to help the company collect and analyze data during its clinical trials. NeuroVigil technology will be used to help the company&#8217;s development of various drugs for [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/5215/roche-inks-deal-with-sleep-monitoring-start-up/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>ScanAvert to aid drug efficacy, avoid food allergies</title>
		<link>http://mobihealthnews.com/4781/scanavert-to-aid-drug-efficacy-avoid-food-allergies/</link>
		<comments>http://mobihealthnews.com/4781/scanavert-to-aid-drug-efficacy-avoid-food-allergies/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 22:00:00 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[food allergies]]></category>
		<category><![CDATA[Health 2.0]]></category>
		<category><![CDATA[medication adherence]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[ScanAvert]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=4781</guid>
		<description><![CDATA[ScanAvert, a wireless health application that alerts users before they eat something that they are allergic to or that might interfere with the effectiveness of their prescription drugs, officially launched today at Health 2.0 in San Francisco. ScanAvert currently runs on Android phones, however, ScanAvert CEO and President Ellen Badinelli told MobiHealthNews that the company [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/4781/scanavert-to-aid-drug-efficacy-avoid-food-allergies/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1.746 seconds -->

